Omnicell, Inc. (OMCL)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 892 | 1,132 | 1,296 | 1,147 | 1,112 | 1,185 | 1,247 | 1,237 |
| Operating profit | $m | 12 | 59 | ||||||
| Net profit | $m | 32 | 78 | 6 | -20 | 13 | 2 | 39 | 106 |
| EPS reported | $ | 0.04 | 0.84 | ||||||
| Operating cashflow per share | $ | 2.77 | 4.02 | ||||||
| Capex per share | $ | 0.88 | 0.91 | ||||||
| FCF per share | $ | 1.89 | 3.11 | ||||||
| Free cash flow | $m | 87 | 141 | ||||||
| Net debt | $m | -44 | -127 | ||||||
| Book value equity | $m | 1,232 | 1,292 | ||||||
| Book value per share | $ | 26.57 | 28.00 | ||||||
| Number of shares | m | 46.36 | 46.13 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | 40.09 | ||||||
| P/B LTM | x | 1.69 | 1.61 | ||||||
| P/S LTM | x | 1.76 | 1.67 | ||||||
| P/FCF LTM | x | 23.97 | 14.73 | ||||||
| EV/EBITDA LTM | x | 20.52 | 19.71 | ||||||
| EV/Sales LTM | x | 1.76 | 1.29 | ||||||
| Earnings Yield LTM | % | +0.10% | +2.49% | ||||||
| FCF Yield | % | +4.17% | +6.79% | ||||||
| Quality | |||||||||
| ROE | % | +0.17% | +3.13% | ||||||
| ROIC | % | +0.14% | +2.41% | ||||||
| Operating margin | % | +0.98% | +4.73% | ||||||
| Gross margin | % | +42.88% | +44.77% | ||||||
| FCF/Sales | % | +7.33% | +11.34% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -83.59% | +211.11% | ||||||
| Sales Growth YoY | % | +6.53% | +12.09% | ||||||
| Net Income Growth YoY | % | -83.62% | +211.89% | ||||||
| FCF Growth | % | -42.56% | -6.52% | ||||||
| Operating Profit Growth | % | +3361.4% | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.43 | 0.71 | ||||||
| Net Debt/EBITDA | x | 0.08 | -0.87 | ||||||
| EBIT/Net interest | x | 2.98 | 14.93 | ||||||
| Net debt/market cap | % | +8.05% | +9.92% | ||||||
| Net debt/Equity | x | -0.04 | -0.10 | ||||||
| Gross debt/equity | x | 0.17 | 0.15 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free